Reference number : 236-2017-2018-Q1-00778, amendment number : , agreement type : G, recipient legal name : Asztalos, Elizabeth V, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M4N 3M5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 1185750.0, agreement start date : 2017-04-01, agreement end date : 2022-03-31, description english : Does bovine lactoferrin (bLF) improve morbidity-free survival and severe retinopathy in very low birthweight infants? The Lactoferrin Infant Feeding Trial (LIFT)., description french : Does bovine lactoferrin (bLF) improve morbidity-free survival and severe retinopathy in very low birthweight infants? The Lactoferrin Infant Feeding Trial (LIFT)., expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2017-18 to 2021-22), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2017-18 à 2021-22), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada